Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients w...

por Johnston, S. R., Constenla, D. O., Moore, J., Atkinson, H., A'Hern, R. P., Dadian, G., Riches, P. G., Gore, M. E.
Publicado 1998